Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.12890/2020_001751 http://scihub22266oqcxt.onion/10.12890/2020_001751 32665935!7350967!32665935     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+J+Case+Rep+Intern+Med 2020 ; 7 (7): 001751 Nephropedia Template TP {{tp|p=32665935|t=2020. Immune Thrombocytopenic Purpura in Patients with COVID-19 |pdf=|usr=}}{{32665935}} gab.com Text Immune Thrombocytopenic Purpura in Patients with COVID-19 JO: Eur J Case Rep Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32665935 #FOAvip We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse. LEARNING POINTS: The severity of haemorrhagic syndrome is not correlated with the severity of COVID-19 infection.Thrombocytopenia in mild COVID-19 infection seems to have an autoimmune mechanism.Intravenous immunoglobulins (1 g/kg) should be the first line of treatment. Twit Text FOAVip Immune Thrombocytopenic Purpura in Patients with COVID-19 ????Eur J Case Rep Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32665935 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32665935 #FOAvip English Wikipedia <ref>{{Cite pmid|32665935}}</ref> Immune Thrombocytopenic Purpura in Patients with COVID-19 #MMPMID32665935 Revuz S; Vernier N; Saadi L; Campagne J; Poussing S; Maurier F Eur J Case Rep Intern Med 2020[]; 7 (7): 001751 PMID32665935show ga We described three COVID-19-infected patients with profound immune thrombocytopenia causing haemorrhagic mucocutaneous complications. We conclude that an immune mechanism was responsible as common causes were excluded. Since corticoids were considered harmful in the circumstances, the patients were successfully treated with intravenous immunoglobulins without later relapse. LEARNING POINTS: The severity of haemorrhagic syndrome is not correlated with the severity of COVID-19 infection.Thrombocytopenia in mild COVID-19 infection seems to have an autoimmune mechanism.Intravenous immunoglobulins (1 g/kg) should be the first line of treatment. äImmune Thrombocytopenic Purpura in Patients with COVID-19 (epmc).pdf DeepDyve Pubget Overpricing